Trials / Unknown
UnknownNCT03547375
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 69 (estimated)
- Sponsor
- Anhui Provincial Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Detailed description
Eligible patients will receive apatinib 500mg/d po until disease progression or intolerable toxicity or patients withdrawal of consent after the failure of chemotherapy or radiotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib | Apatinib 500mg/d po,28 days as one cycle |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2019-12-01
- Completion
- 2020-06-01
- First posted
- 2018-06-06
- Last updated
- 2018-06-06
Source: ClinicalTrials.gov record NCT03547375. Inclusion in this directory is not an endorsement.